Ncardia
Jessica Koepke has built an extensive career in the field of scientific research and development, with a strong focus on biology and genetics. Jessica has held various technician and scientist roles in reputable companies such as Ncardia, Charles River Laboratories, Galapagos BV, Arthrogen b.v., Crucell, Max-Planck Institute for Psychiatry, and GSF. Their expertise ranges from in vivo/in vitro development of new compounds to creating mouse models for neurodegenerative diseases. Jessica's educational background includes a degree in Biology from Berufsfachschule Greifswald GmbH.
Ncardia
Ncardia is a drug discovery company and expert in human iPSC technology. We operate worldwide with facilities, offices and staff throughout Europe and North America. We work with biopharmaceutical companies in drug discovery worldwide, to leverage the power of stem cell technologies in the development of novel therapies of multiple modalities at any stage of development. Over the past 10 years, we have built the expertise and infrastructure required to differentiate, manufacture and characterize high-quality iPSC-derived cell and disease models. We can facilitate the process of disease modeling and high-throughput screening to accelerate drug discovery. We listen to our customer’s project plans, questions and challenges, and co-develop human iPSC-based solutions that fit their specifications. Explore our website to learn more www.ncardia.com.